Ex-vivo expanded allogeneic γδ T cells
IIT2025056
Phase 1 mab active
Quick answer
Ex-vivo expanded allogeneic γδ T cells for AML (Acute Myelogenous Leukemia) is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- AML (Acute Myelogenous Leukemia)
- Phase
- Phase 1
- Modality
- mab
- Status
- active